Donaldson Company (DCI) CL King's 22nd Annual Best Ideas Conference 2024 summary

Company overview and strategy

• Over 100 years in filtration, with 2,800 active patents and a focus on technology-led solutions.

• Operates in Mobile Solutions, Industrial, and Life Sciences, with recent expansion into Life Sciences.

• Revenue split: 62% Mobile Solutions, 30% Industrial, 8% Life Sciences; revenues grew from $2.8B in 2021 to $3.6B in FY 2024.

• Maintains a global footprint with 140 locations and over 50 manufacturing facilities.

• Emphasizes aftermarket sales, with 66% of business in replacement products.

Financial performance and outlook

• Achieved record sales and profits in recent years, with FY 2025 revenue expected to grow 4% to $3.7B.

• Adjusted EPS increased from $2.32 in 2021 to $3.42 in FY 2024, with continued growth expected.

• Operating margin has consistently improved, with further increases targeted.

• Net debt-to-EBITDA ratio at 0.5, below the target of 1, reflecting strong cash generation and disciplined capital deployment.

• Share buybacks increased to 2-3% of shares for the current fiscal year.

Business segment highlights

• Mobile Solutions targets efficiency and clean operation in construction, agriculture, and mining.

• Industrial Solutions focuses on connected products, enabling customers to optimize equipment and energy use.

• Life Sciences segment built through acquisitions and organic growth, leveraging membrane technologies for new markets.

• Recent 49% stake in Medica enhances Life Sciences with advanced membrane and dialysis technologies.

• Technology sharing across segments supports innovation and growth.